Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/1998
02/10/1998US5716611 Topical formulation including water soluble emollient comprising ethoxylated higher aliphatic alcohol and ethoxylated cholesterol derivative
02/10/1998US5716610 A mixture of water soluble vinyl polymer gel, amine alcohol dispersant, water and histamine phosphate is used topically to treat herpes labialis and/genitalis, chicken pox, heat and sun burn, aphthous stomatitis, allergic conjunctivitis
02/10/1998US5716609 Therapeutic anti-inflammatory and analgesic composition containing nimesulide for use transdermally and a process for the manufacture thereof
02/10/1998US5716608 Methods to inhibit acute radiation-induced skin damage
02/10/1998US5716607 Preapplying a layer of biocompatible polymer
02/10/1998US5716406 Sterilizing by soaking the medical equipments in a solution containing antiinflammatory drugs prior to insertion or implantation in human or mammal
02/10/1998US5715835 Methods for treating and reducing the potential for cardiovascular disease using methioninase compositions
02/10/1998CA2116234C Use of n-acetyl-l-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
02/10/1998CA2112351C Method of making camptothecin and camptothecin analogs
02/10/1998CA2094914C Anthracycline analogues bearing latent alkylating substituents
02/10/1998CA2079205C Use of hyaluronic acid and forms to prevent arterial restenosis
02/10/1998CA2053258C Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption
02/10/1998CA2053065C Cyclophosphamide - sodium bicarbonate lyophilizates
02/10/1998CA2005695C Use of salicylated derivatives for the treatment of skin aging
02/10/1998CA2001389C Pyrimidinedione derivative compounds, method of producing the same and antiarrythmic agents containing the same
02/10/1998CA1339663C 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivate, processfor producingthem and use thereof
02/10/1998CA1339661C Cycloalkylamides of (8b)-1alkyl-6 (substituted)ergolines
02/09/1998CA2184799A1 Nifedipine containing pharmaceutical extended release composition and a process for the preparation thereof
02/07/1998CA2210415A1 Xanthene and acridine derivatives and their use
02/06/1998CA2212204A1 8-substituted b-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators
02/05/1998WO1998004913A1 Molecular model for vla-4 inhibitors
02/05/1998WO1998004734A1 Synthetic protein folding catalysis
02/05/1998WO1998004732A1 SYNTHESIS OF β-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE
02/05/1998WO1998004714A1 A NOVEL HUMAN mRNA EDITING ENZYME
02/05/1998WO1998004705A1 Pharmaceutical composition for treating papillomavirus tumours and infection
02/05/1998WO1998004702A2 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use
02/05/1998WO1998004691A1 Human proteolipid
02/05/1998WO1998004686A2 Pro-protein converting enzyme
02/05/1998WO1998004682A1 Adipogenic differentiation of human mesenchymal stem cells
02/05/1998WO1998004585A2 Novel human macrophage antigen
02/05/1998WO1998004574A1 Preparation of crystal form ii of clarithromycin
02/05/1998WO1998004573A1 Crystal form i of clarithromycin
02/05/1998WO1998004569A1 Nucleotide analogs
02/05/1998WO1998004561A1 1-azoniabicyclo[2.2.1]heptane derivatives and pharmaceutical compositions containing them
02/05/1998WO1998004560A1 SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABAAα5 RECEPTOR SUBTYPE
02/05/1998WO1998004559A2 Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
02/05/1998WO1998004558A1 Active oxygen scavengers containing pterin derivatives
02/05/1998WO1998004556A1 Pyridazino [4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
02/05/1998WO1998004555A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
02/05/1998WO1998004553A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
02/05/1998WO1998004552A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
02/05/1998WO1998004551A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
02/05/1998WO1998004545A1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
02/05/1998WO1998004541A1 Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease
02/05/1998WO1998004537A1 Novel compounds and compositions for treating diseases associated with tryptase activity
02/05/1998WO1998004530A1 Parasiticidal pyrazoles
02/05/1998WO1998004528A2 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
02/05/1998WO1998004527A1 Pyranoindole and carbazole inhibitors of cox-2
02/05/1998WO1998004526A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
02/05/1998WO1998004524A1 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
02/05/1998WO1998004521A1 Potassium channel inhibitors
02/05/1998WO1998004517A1 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
02/05/1998WO1998004513A1 Water-miscible esters of monoglycerides having antimicrobial activity
02/05/1998WO1998004508A1 NOVEL p-TERPHENYL COMPOUNDS
02/05/1998WO1998004394A1 A process to manufacture sustained release medicaments
02/05/1998WO1998004312A1 Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide
02/05/1998WO1998004291A1 2-methoxyestradiol-induced apoptosis in cancer cells
02/05/1998WO1998004290A2 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
02/05/1998WO1998004289A2 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist
02/05/1998WO1998004283A1 Antiprotozoal composition
02/05/1998WO1998004279A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
02/05/1998WO1998004272A1 Chlamydia oligosaccharides
02/05/1998WO1998004270A1 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition
02/05/1998WO1998004269A1 Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
02/05/1998WO1998004268A1 Oral contraceptive
02/05/1998WO1998004267A1 Progestin/estrogen oral contraceptive
02/05/1998WO1998004266A1 Oral contraceptive
02/05/1998WO1998004265A1 Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
02/05/1998WO1998004264A1 Methods and compositions to inhibit keratinocyte proliferation
02/05/1998WO1998004263A1 Methods and compositions to inhibit keratinocyte proliferation
02/05/1998WO1998004262A1 Prophylaxis and therapy of the consequences of a lack of cerebral blood circulation and of neurodegenerative diseases
02/05/1998WO1998004261A1 Nefazodone: use in migraine prophylaxis
02/05/1998WO1998004260A1 Substituted biphenyl sulfonamide endothelin antagonists
02/05/1998WO1998004259A1 ANTITHROMBOTIC AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION INCLUDING A THIENOPYRIDINE DERIVATIVE AND AN HMG-CoA-REDUCTASE INHIBITOR
02/05/1998WO1998004258A1 Formulation for the treatment and/or prophylaxis of dementia
02/05/1998WO1998004257A1 Phosphatase inhibitors and methods of use thereof
02/05/1998WO1998004256A1 Amino acid compositions and use thereof in immunosuppression
02/05/1998WO1998004255A1 Amino acid composition and use thereof in treating tumor growth and metastasis
02/05/1998WO1998004254A1 Composition of pyruvate and protein and method for increasing protein concentration in a mammal
02/05/1998WO1998004253A1 Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
02/05/1998WO1998004252A1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing same
02/05/1998WO1998004251A1 Use of amines to produce drugs for preventing tumour cell proliferation
02/05/1998WO1998004250A1 Pharmaceutical compositions for the reversion of multiple resistance to drugs
02/05/1998WO1998004249A2 Tramadol multiple unit formulations
02/05/1998WO1998004248A1 Dietary supplements
02/05/1998WO1998004247A1 Cell adhesion inhibitors
02/05/1998WO1998004246A2 Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
02/05/1998WO1998004245A1 Use of transglutaminase modulators to promote wound healing
02/05/1998WO1998004242A2 Tumor delivery vehicles and method to enhance treatment of cystic tumors
02/05/1998WO1998004236A2 Antiperspirant or deodorant composition with silicone latex
02/05/1998WO1998004157A1 Nutritional formulations containing water-miscible lipid derivatives as antimicrobial agents
02/05/1998WO1998004135A1 Diphenyl heterocycles as potassium channel modulators
02/05/1998WO1998004133A1 Methods of treating asthma with o-desulfated heparin
02/05/1998WO1998004132A1 Treatment of central nervous system diseases with nitric oxide or peroxynitrite scavengers
02/05/1998WO1998004131A1 Methods of treatment of eye trauma and disorders
02/05/1998WO1998004127A2 Transplant solutions containing pyruvate and methods for transplantation
02/05/1998WO1997049736A3 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
02/05/1998WO1997048369A3 Prophylactic and therapeutic treatment of skin sensitization and irritation
02/05/1998WO1997048368A3 Naphthyridines which affect il-4 and g-csf
02/05/1998WO1997048367A3 Compositions for the treatment of chronic infections containing glucocorticoid and antiglucocorticoid